SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027698
Filing Date
2021-11-09
Accepted
2021-11-09 17:21:28
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1315676
2 ex-31.htm EX-31 30100
3 ex-32.htm EX-32 7836
  Complete submission text file 0001493152-21-027698.txt   7917917

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ocx-20210930.xsd EX-101.SCH 73222
5 XBRL CALCULATION FILE ocx-20210930_cal.xml EX-101.CAL 70836
6 XBRL DEFINITION FILE ocx-20210930_def.xml EX-101.DEF 313043
7 XBRL LABEL FILE ocx-20210930_lab.xml EX-101.LAB 549210
8 XBRL PRESENTATION FILE ocx-20210930_pre.xml EX-101.PRE 438739
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1315059
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 211393337
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences